Metolod 23.75mg Tablet ER

Overview Metolod 23.75mg Tablet ER

Cardilock 23.75mg Extended-Release Tablets are classified as beta-blockers, employed in managing hypertension, angina pectoris (chest discomfort linked to the heart), and cardiac arrhythmias. This medication also aids in migraine prophylaxis and reducing the risk of future strokes and myocardial infarctions. Cardilock 23.75mg ER may be administered independently or in conjunction with other therapies; dosage and frequency are condition-specific and determined by your physician. Ingestion may occur with or without food, but consistent daily timing is crucial for optimal efficacy. Complete therapeutic benefits might take several weeks to manifest, and continuous use may be necessary. Discontinuation can exacerbate underlying conditions, even in the absence of noticeable symptoms. Common adverse effects include fatigue, cephalalgia, depressive symptoms, diarrhea, skin rashes, bradycardia, lightheadedness, and nausea—typically mild and transient. Less frequent but possible side effects include dyspnea and hypotension. Gradual dosage escalation, starting with a low dose, minimizes adverse event likelihood. Report persistent or troublesome side effects to your doctor. Prior to commencement, inform your physician of any hepatic impairment. This medication may be unsuitable for individuals with bradycardia, significant circulatory issues, severe congestive heart failure, or hypotension. Pregnant or lactating women should seek medical advice. Individual suitability should be discussed with a healthcare professional. Regular blood pressure monitoring is essential to assess treatment efficacy. Alcohol consumption should be limited due to potential exacerbation of certain side effects.

Primary Ingredients of Metolod 23.75mg Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Metolod 23.75mg Tablet ER

Managing angina pectoris (chest pain from heart conditions)|Correcting cardiac arrhythmias|Preventing myocardial infarction|Hypertension (high blood pressure) management|Migraine prophylaxis

Major Benefits of Metolod 23.75mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metolod 23.75mg Extended-Release tablet whole; do not chew, crush, or break it. While this medication can be taken with or without food, consistent timing is recommended. Limit consumption of high-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and fatty meats, while taking Metolod 23.75mg Tablet ER.

Common Side effects of Metolod 23.75mg Tablet ER:

• Tiredness
• Dizziness
• Depression
• Breathlessness
• Headache
• Slow heart rate
• Nausea
• Rash
• Diarrhea
• Hypotension (low blood pressure)

How to use Metolod 23.75mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metolod 23.75mg Extended-Release Tablets can be taken with or without food, however, consistent timing is recommended. Limit consumption of Metolod 23.75mg Extended-Release Tablets with meals high in fat, including, but not limited to, olive oil, nuts and seeds (particularly Brazil nuts), dark chocolate, butter, and fatty meats.

How Metolod 23.75mg Tablet ER works:

Extended-release Metolod 23.75mg tablets are a cardioselective beta-adrenergic blocking agent, reducing heart rate and improving the heart's pumping efficiency.

What if you forget to take Metolod 23.75mg Tablet ER :

Should you forget to take a Metolod 23.75mg Extended-Release tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.